| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8815444 | Journal of Affective Disorders | 2018 | 37 Pages |
Abstract
TAU content and quality represents an important source of heterogeneity between trials of psychotherapeutic interventions for prevention of self-harm. Before clinical trials begin, researchers should plan to carefully describe both aspects of TAU to improve the overall quality of investigations.
Related Topics
Health Sciences
Medicine and Dentistry
Psychiatry and Mental Health
Authors
Katrina Witt, Daniela Pache de Moraes, Tatiana Taylor Salisbury, Ella Arensman, David Gunnell, Philip Hazell, Ellen Townsend, Kees van Heeringen, Keith Hawton,